Skip to main content
SpringerLink
Log in

Pamaqueside

CP 148623

  • Original Research Article
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Wilson TC, Biehl ML, Cole MJ, et al. Pharmacokinetics of the novel cholesterol absorption inhibitor, CP-148,623, in Sprague-Dawley rats, beagle dogs and cynomolgus monkeys. ISSX Proceedings 6: 110, 1994

    Google Scholar 

  2. Harris WS, Windsor SL, Newton FA, et al. Inhibition of cholesterol absorption with CP-148,623 lowers serum cholesterol in humans. Clin Pharmacol Ther 61: 385–389, Mar 1997

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pamaqueside. Drugs R&D 3, 175–176 (2002). https://doi.org/10.2165/00126839-200203030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203030-00006

Keywords

Search

Navigation